281 related articles for article (PubMed ID: 16987684)
1. [Levonorgestrel-releasing intrauterine system in the treatment of dysfunctional uterine bleeding: A French multicenter study].
Yazbeck C; Omnes S; Vacher-Lavenu MC; Madelenat P
Gynecol Obstet Fertil; 2006 Oct; 34(10):906-13. PubMed ID: 16987684
[TBL] [Abstract][Full Text] [Related]
2. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
3. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.
Crosignani PG; Vercellini P; Mosconi P; Oldani S; Cortesi I; De Giorgi O
Obstet Gynecol; 1997 Aug; 90(2):257-63. PubMed ID: 9241305
[TBL] [Abstract][Full Text] [Related]
4. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
Bourdrez P; Bongers MY; Mol BW
Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
[TBL] [Abstract][Full Text] [Related]
5. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W
Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd:YAG laser for the treatment of dysfunctional uterine bleeding.
Hawe J; Abbott J; Hunter D; Phillips G; Garry R
BJOG; 2003 Apr; 110(4):350-7. PubMed ID: 12699795
[TBL] [Abstract][Full Text] [Related]
7. Current treatment of dysfunctional uterine bleeding.
Bongers MY; Mol BW; Brölmann HA
Maturitas; 2004 Mar; 47(3):159-74. PubMed ID: 15036486
[TBL] [Abstract][Full Text] [Related]
8. The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.
Gunes M; Ozdegirmenci O; Kayikcioglu F; Haberal A; Kaplan M
J Minim Invasive Gynecol; 2008; 15(6):735-8. PubMed ID: 18971138
[TBL] [Abstract][Full Text] [Related]
9. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
10. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
Busfield RA; Farquhar CM; Sowter MC; Lethaby A; Sprecher M; Yu Y; Sadler LC; Brown P; Johnson N
BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection.
Rauramo I; Elo I; Istre O
Obstet Gynecol; 2004 Dec; 104(6):1314-21. PubMed ID: 15572496
[TBL] [Abstract][Full Text] [Related]
12. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
Rosa e Silva JC; de Sá Rosa e Silva AC; Cândido dos Reis FJ; Manetta LA; Ferriani RA; Nogueira AA
J Reprod Med; 2005 Aug; 50(8):613-7. PubMed ID: 16220768
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect on the treatment of menorrhagia by endometrial biopsy followed by contemporaneous insertion of the levonorgestrel intrauterine system.
Baron YM; Craus J; Agius RC; Brincat M
Gynecol Endocrinol; 2012 Sep; 28(9):694-8. PubMed ID: 22304721
[TBL] [Abstract][Full Text] [Related]
14. The effect of the levonorgestrel intrauterine system on uterine artery blood flow 1 year after insertion.
Haberal A; Kayikcioglu F; Gunes M; Kaplan M; Ozdegirmenci O
Ultrasound Obstet Gynecol; 2006 Mar; 27(3):316-9. PubMed ID: 16450358
[TBL] [Abstract][Full Text] [Related]
15. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
Wildemeersch D; Rowe PJ
Contraception; 2005 Jun; 71(6):470-3. PubMed ID: 15914139
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia.
Kriplani A; Singh BM; Lal S; Agarwal N
Int J Gynaecol Obstet; 2007 Jun; 97(3):190-4. PubMed ID: 17382331
[TBL] [Abstract][Full Text] [Related]
17. Levonorgestrel-releasing intrauterine device insertion ameliorates leiomyoma-dependent menorrhagia among women of reproductive age without a significant regression in the uterine and leiomyoma volumes.
Murat Naki M; Tekcan C; Ozcan N; Cebi M
Fertil Steril; 2010 Jun; 94(1):371-4. PubMed ID: 19896649
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of levonorgestrel releasing IUD and thermal balloon ablation in the treatment of menorrhagia.
Soysal M; Soysal S; Ozer S
Zentralbl Gynakol; 2002 Apr; 124(4):213-9. PubMed ID: 12080483
[TBL] [Abstract][Full Text] [Related]
19. Treatment of menorrhagia with an LNG-IUS.
Pakarinen P; Luukkainen T
Contraception; 2007 Jun; 75(6 Suppl):S118-22. PubMed ID: 17531601
[TBL] [Abstract][Full Text] [Related]
20. A 52-mg levonorgestrel-releasing intrauterine system vs bipolar radiofrequency nonresectoscopic endometrial ablation in women with heavy menstrual bleeding: long-term follow-up of a multicenter randomized controlled trial.
Huijs DPC; Derickx AJM; Beelen P; Leemans JC; van Kuijk SMJ; Bongers MY; Geomini PMAJ
Am J Obstet Gynecol; 2024 May; 230(5):542.e1-542.e10. PubMed ID: 38280433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]